Razazi Keyvan, Boissier Florence, Surenaud Mathieu, Bedet Alexandre, Seemann Aurélien, Carteaux Guillaume, de Prost Nicolas, Brun-Buisson Christian, Hue Sophie, Mekontso Dessap Armand
AP-HP, Service de Réanimation Médicale, Hôpitaux universitaires Henri Mondor, DHU A-TVB, 94010, Créteil, France.
IMRB, GRC CARMAS, Faculté de Médecine de Créteil, Université Paris Est Créteil, 94010, Créteil, France.
Ann Intensive Care. 2019 Jun 4;9(1):64. doi: 10.1186/s13613-019-0538-3.
The mechanisms of organ failure during sepsis are not fully understood. The hypothesis of circulating factors has been suggested to explain septic myocardial dysfunction. We explored the biological coherence of a large panel of sepsis mediators and their clinical relevance in septic myocardial dysfunction and organ failures during human septic shock.
Plasma concentrations of 24 mediators were assessed on the first day of septic shock using a multi-analyte cytokine kit. Septic myocardial dysfunction and organ failures were assessed using left ventricle ejection fraction (LVEF) and the Sequential Organ Failure Assessment score, respectively.
Seventy-four patients with septic shock (and without immunosuppression or chronic heart failure) were prospectively included. Twenty-four patients (32%) had septic myocardial dysfunction (as defined by LVEF < 45%) and 30 (41%) died in ICU. Hierarchical clustering identified three main clusters of sepsis mediators, which were clinically meaningful. One cluster involved inflammatory cytokines of innate immunity, most of which were associated with septic myocardial dysfunction, organ failures and death; inflammatory cytokines associated with septic myocardial dysfunction had an additive effect. Another cluster involving adaptive immunity and repair (with IL-17/IFN pathway and VEGF) correlated tightly with a surrogate of early sepsis resolution (lactate clearance) and ICU survival.
In this preliminary study, we identified a cluster of cytokines involved in innate inflammatory response associated with septic myocardial dysfunction and organ failures, whereas the IL-17/IFN pathway was associated with a faster sepsis resolution and a better survival.
脓毒症期间器官衰竭的机制尚未完全明确。循环因子假说被提出用于解释脓毒症性心肌功能障碍。我们探讨了一大组脓毒症介质的生物学关联性及其在人类脓毒性休克期间脓毒症性心肌功能障碍和器官衰竭中的临床相关性。
使用多分析物细胞因子检测试剂盒在脓毒性休克的第一天评估24种介质的血浆浓度。分别使用左心室射血分数(LVEF)和序贯器官衰竭评估评分来评估脓毒症性心肌功能障碍和器官衰竭。
前瞻性纳入了74例脓毒性休克患者(无免疫抑制或慢性心力衰竭)。24例患者(32%)发生脓毒症性心肌功能障碍(定义为LVEF<45%),30例(41%)在重症监护病房死亡。层次聚类分析确定了脓毒症介质的三个主要聚类,具有临床意义。一个聚类涉及固有免疫的炎性细胞因子,其中大多数与脓毒症性心肌功能障碍、器官衰竭和死亡相关;与脓毒症性心肌功能障碍相关的炎性细胞因子具有累加效应。另一个涉及适应性免疫和修复的聚类(与IL-17/IFN途径和VEGF相关)与早期脓毒症缓解的替代指标(乳酸清除率)和重症监护病房生存率密切相关。
在这项初步研究中,我们确定了一组与脓毒症性心肌功能障碍和器官衰竭相关的参与固有炎症反应的细胞因子,而IL-17/IFN途径与脓毒症更快缓解和更好的生存率相关。